Overview Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects Status: Recruiting Trial end date: 2023-12-01 Target enrollment: Participant gender: Summary This is an open-label, multi-center, Phase 3 study to evaluate tapinarof cream, 1% in pediatric subjects with plaque psoriasis. Phase: Phase 3 Details Lead Sponsor: Dermavant Sciences, Inc.